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Transthoracic lung and mediastinal biopsies obtained with the
Tru-Cut technique: 10 years’ experience
Şerife SAVAŞ BOZBAŞ1, Şule AKÇAY1, Figen ÖZTÜRK ERGÜR1, Cüneyt AYTEKİN2

Aim: Percutaneous needle biopsy has been used successfully in many organ systems with excellent results and few
complications. In this study, we sought to evaluate percutaneous transthoracic biopsy results using a coaxial system.
Materials and methods: The records of 302 patients (mean age, 63.1 years) who underwent percutaneous CT-guided
coaxial cutting needle lung and mediastinal biopsy were retrospectively evaluated. Number, diameter, location of the
lesions, calcification, and emphysema on lung parenchyma were noted. The number of specimens obtained, complications
after the procedure, and treatment of complications were recorded.
Results: From lesions identified in 270 patients on thoracic CT, a mean of 5.6 biopsy specimens were obtained in 1
procedure. Pathology results of transthoracic biopsies were achieved in 258 patients (95.5%), of whom 226 (87.5%) were
diagnostic. At the final diagnosis, 178 biopsy results (68.9%) demonstrated malignancy. Complications were observed in
68 patients (25.1%). No relationship of age, sex, presence of emphysema on lung parenchyma, or the number of biopsy
specimens obtained with the development of complications was observed.
Conclusion: Transthoracic lung and mediastinal biopsy using a coaxial system is a well tolerated, minimally invasive
procedure that has a high diagnosis rate, provides reliable differentiation of malignant and benign lesions, and has an
acceptable rate of complications.
Key words: Tru-Cut lung biopsy, lung lesions, pneumothorax

Tru-Cut tekniği kullanılarak alınan transtorasik akciğer ve mediastinal biyopsiler: 10
yıllık deneyim
Amaç: Perkütan iğne biyopsileri düşük komplikasyon ve yüksek tanı oranları nedeniyle organ patolojilerinin çoğunda
başarıyla uygulanmaktadır. Çalışmamızda coaxial sistem kullanılarak yapılan transtorasik biyopsi sonuçlarını
değerlendirmeyi amaçladık.
Yöntem ve gereç: Perkütan BT-aracılı coaxial akciğer ve mediastinal biyopsi yapılan 302 hasta (ortalama yaş, 63,1 ± 13,2
yıl) retrospektif olarak incelendi. Lezyon sayısı, çapı, lokalizasyonu, kalsifikasyon içerip içermediği ve akciğer
parankiminde amfizem varlığı kaydedildi. İşlem sırasında alınan örnek sayısı, komplikasyon gelişimi ve
komplikasyonların tedavisi not edildi.
Bulgular: Toraks BT’de lezyon saptanan 270 hastadan işlem sırasında ortalama 5.6 biyopsi alınmıştı. Transtorasik biyopsi
yapılan hastalardan 258 (% 95.5)’inin patoloji sonucuna ulaşılabildi ve 226 (% 87,5)’sı tanısal olarak değerlendirildi. Bu
çalışmada, 178 (% 68,9) hastanın biyopsi sonucu malignite ile uyumlu idi. Hastalardan 68 (% 25,1)’inde komplikasyon
saptandı. Komplikasyon gelişimi ile yaş, cinsiyet, amfizem varlığı ve biyopsi sayısı arasında ilişki saptanmadı.
Sonuç: Coaxial sistem kullanılarak alınan transtorasik akciğer ve mediastinal biyopsiler yüksek tanı oranları ve düşük
(kabul edilebilir) komplikasyon oranlarına sahiptir.
Anahtar sözcükler: Perkütan akciğer biyopsisi, akciğer lezyonları, pnömotoraks
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Introduction
Bronchoscopic and percutaneous lung biopsies are
commonly used for specific cytologic and
histopathologic diagnoses of pulmonary lesions. The
diagnostic accuracy of flexible bronchoscopy is high
for centrally located lesions. However, its diagnostic
value for peripherally located lesions is lower (1).
When bronchoscopic methods are insufficient,
transthoracic lung biopsy is commonly used for
histologic diagnosis and classification of lesions.
Reasons for performing percutaneous lung biopsy
include diagnosing primary and metastatic
malignancies and benign lesions, obtaining a
specimen for culture, and performing other
microbiologic tests.
For diagnosis of focal lung lesions, percutaneous
coaxial cutting needle lung biopsy guided by
computed tomography (CT) has been accepted as an
initial method (2). Compared with fine needle
aspiration, cutting needle biopsy provides better
diagnostic accuracy of benign lung lesions and a
similarly high degree of diagnostic accuracy of
malignant lung lesions, with acceptably low risks and
no need for an on-site cytology team (3). Diagnostic
accuracy rates for cutting needle lung biopsy have
been reported as ranging from 76% to 93% despite the
use of a standard CT-guided coaxial technique (2).
Percutaneous needle biopsy has been successfully
applied in many organ systems with excellent results
and few complications (4). In this retrospective study,
we sought to evaluate percutaneous transthoracic
biopsy results.
Materials and methods
From November 1996 to June 2007, percutaneous
transthoracic CT-guided coaxial cutting needle biopsy
procedures were performed in 302 patients. The
records of these patients were retrospectively
evaluated. Of the 302 subjects, 32 were excluded from
the analysis because their records were not available
since they had been referred from other centers only
for the biopsy procedure. All patients who underwent
percutaneous transthoracic lung biopsy had focal lung
lesions presenting as a nodule, a mass, or a mass like
consolidation. Thoracic CT scans of 270 patients were
examined. The number, diameter, and location
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(central, peripheral, and mediastinal) of the lesions as
well as the presence or absence of calcification and
emphysema on lung parenchyma were noted.
Radiologically, lesions that were located proximal to
the segment bronchus were defined as central, and
those located distal to segment bronchus were
accepted as peripheral. Lesion size was measured
along the maximum long axis diameter. Prior to
percutaneous lung biopsy procedures, platelet counts,
prothrombin time, and activated thromboplastin time
of all the participants were recorded. Detailed
information including the necessity of the procedures,
how the procedures would be performed, possible
complications, and how these complications would be
treated were explained to each subject. Written
informed consent was obtained from all patients. All
biopsies were performed by 2 interventional
radiologists. The study protocol was approved by the
local research ethics committee.
Patients were positioned on the tomography table
and were aligned in the best position with regard to
the lesion location; slice images of 3 to 5 mm were
obtained. Metallic signs were placed on the skin to
define the exact insertion site. After appropriate
cleaning and sterilization of the skin, local anesthesia
was applied, and a small incision was made to
facilitate passage of the needle. A 16-G needle at an
appropriate angle to the lesion was inserted. During
the biopsy procedure, a removable hub system
(vanSonnenberg, Cook Bjaeverskov, Denmark) was
used. This system is composed of a 19-G outer
cannula, a 22-G inner cannula containing a removable
hub, and a 23-G mandrel. The 22-G needle with its
mandrel passing through the 16-G needle was placed
into the lesion. After CT images had confirmed that
the 22-G needle was correctly positioned into the
lesion, the hub of 22-G needle and the mandrel were
removed. After removal of the 16-G needle, using the
22-G needle as guidewire, the 19-G outer cannula was
placed at the edge of the lesion. Using a 21-G Autovac
biopsy needle (Bard, Karlsruhe, Germany) through
the 19-G cannula, Tru-Cut biopsies were obtained. At
the end of the biopsy procedure and 1 h after the
procedure, control thoracic CT scans were obtained.
If a pneumothorax was detected, air in the pleural
space was aspirated while withdrawing the cannula.
If patients had no symptoms and no increase in the
pneumothorax on follow-up, no intervention was
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performed. If aspiration was inadequate or if a large or
rapidly enlarging pneumothorax was found, a chest
tube was placed into the pleural space. The tubes used
were of various types of locking loop pigtail catheters
(usually 8 or 10 F). A pleural catheter was inserted for
water drainage and kept in place for at least 24 h. If
the pneumothorax resolved, the chest tube was
removed and the patient was discharged. Obtained
specimens were put in a solution containing formalin
and sent to the pathology laboratory for analysis and
in isotonic saline for culture.
Patients with abnormal clotting function,
thrombocytopenia, suspected hydatid cyst or
arteriovenous malformation, mechanical ventilation
that could lead to pneumothorax or air embolism,
inability to suspend respiration or control cough on
request, and those who could not tolerate a recumbent
position were excluded.
The number of specimens obtained and
complications (pneumothorax, bleeding, hemoptysis,
etc) after the procedure were noted. Interventions to
treat complications were recorded. Transthoracic
biopsy results were classified into 3 groups: malignant,
benign, and nondiagnostic results.
Data analyses
Statistical analyses were performed with SPSS
(version 10.0, SSPS Inc, Chicago, IL, USA).
Continuous variables are presented as means ±
standard deviation, and differences between patients
were evaluated with the unpaired t test. Categorical
variables are reported as group percentages. The chisquare test was used to compare categorical variables.
All P values are 2-sided, and values <0.05 were
considered statistically significant.
Results
Transthoracic biopsy using a coaxial system was
performed on 302 patients. Complete records were
available in 270 patients. The mean age of the patients
was 63.1 ± 13.2 years; 68 (25.2%) were female and 202
(74.8%) were male. With regard to the number of
lesions on CT, there were 165 (61.1%) single lesions,
2 lesions in 24 patients (8.8%), and multiple lesions in
81 patients (30.1%). The mean number of lesions was
2.3, and the mean long axis diameter was 40.2 ± 21.4
mm. Calcification and emphysema were noted in 13

(4.8%) and 72 (27.6%) patients, respectively. The
locations of the lesions on thoracic CT are presented
in Table 1.
Table 1. Localization of the lesions on Thorax CT.
Localization

n

%

Central

32

12.2

Peripheral

165

63.0

Mediastinal

35

13.4

Central + Peripheral + Mediastinal

38

11.4

Pathology results of transthoracic biopsy were
achieved in 258 patients (95.5%), of whom the results
were diagnostic in 226 (87.4%). At the final diagnosis,
the biopsy results were malignant in 178 patients
(68.9%) and they were benign in 48 patients (18.5%).
The pathology results were nondiagnostic in 32
patients (12.6%). In 12 patients (4.4%), a pathology
result was not available in the patient records. Biopsy
results are presented in Table 2.
From lesions identified on thoracic CT, a mean of
5.6 biopsy specimens were obtained from each
patient. In 1 patient with severe emphysema,
pneumothorax developed on our first attempt, and
thus a biopsy specimen could not be obtained.
Complications were observed in 68 (25.1%) of 270
patients in whom a transthoracic biopsy was
performed. Pneumothorax developed in 59 patients
(21.8%); a drainage tube was needed in 22 of them. A
pigtail catheter was used for tube drainage, after
underwater seal drainage in all of the patients, the
pneumothorax resolved and surgery was not needed.
In patients with bleeding and hemoptysis, no
additional therapeutic intervention was needed on
follow-up. The complications observed after
transthoracic biopsy and therapy for these
complications are summarized in Table 3.
With regard to complications, age, sex,
emphysema on lung parenchyma, and the number of
biopsy specimens obtained had no effect on the
development of complications (P > 0.05 for all).
Complications were noted in 28% of the males and
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Table 2. Histopathologic findings for 258 transthoracic biopsy.
n

%

178

68.9

Small cell lung cancer

12

4.7

Non-small cell lung cancer

42

16.3

Adenocarcinoma

53

20.5

Squamous cell carcinoma

12

4.7

1

0.3

Carcinomas

40

15.5

Metastatic lung carcinomas

8

3.1

Solitary fibrous tumors

1

0.3

Thymoma

3

1.3

Thymic carcinoma

1

0.3

Anaplastic cells

1

0.3

Atypical cells

2

0.8

Lymphoma infiltration

2

0.8

48

18.5

Granulomatous reaction

14

5.4

Chronic inflammation

5

1.9

Acute inflammation

8

3.1

Aspergilloma

4

1.5

Lymphoid tissue

2

0.8

Plasma cell granuloma

2

0.8

Reactive mesothelial cells

1

0.3

Hydatid cyst

2

0.8

Interstitial fibrosis

6

2.3

Hyalinized tissue

3

1.3

Rheumatoid nodule

1

0.3

32

12.6

Necrosis

7

2.7

Blood components

6

2.3

Lung parenchyma

6

2.3

Bronchial tissue

4

1.5

Benign cells

3

1.2

Cartilage tissue

3

1.3

Anthracosis

3

1.3

Malignant Lesions

Large cell carcinoma

Benign Lesions

Nondiagnostic results
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Table 3. Complications and treatments after transthoracic lung
biopsy.
n

%

57
35
22

21.1
61.4
38.6

Bleeding
observation

7
7

2.6
100

Hemoptysis
observation

2
2

0.7
100

Pneumothorax and bleeding
observation

2
2

0.7
100

Pneumothorax
observation
Tube drainage

16.4% of females (P > 0.05). Location of the lesion
(peripheral, central, or mediastinal) did not affect the
complication rate (P > 0.05). When the lesions were
classified according to diameter as <2 cm, 2-3 cm, and
>3 cm, the rates of complications were 28.3%, 33.3%,
and 21.1%, respectively; no significant difference was
detected among these subgroups (P = 0.1). The
complication rate was significantly higher in calcific
lesions than in lesions without calcification (53.8% vs.
23.3%; P = 0.02). Complications were seen in 19
(26.4%) of 72 patients with emphysema. No
differences were detected in complication rates
between benign and malignant lesions (24.3% vs.
24.2%, respectively; P > 0.05).
Discussion
Since it is not always possible to obtain adequate
specimens by fine needle aspiration biopsy for
histologic diagnoses, a Tru-Cut biopsy technique is
commonly used for many solid organ lesions.
Although the fine needle aspiration biopsy technique
has a high sensitivity for diagnosing malignant
lesions, a biopsy obtained using a coaxial system has
the advantage of defining the specific subtype of the
lesion.
Needles are divided into 2 broad categories,
aspiration needles for cytology and cutting needles for
histology samples. Large tissue cores are obtained
with a powered Tru-Cut needle with throw lengths of
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1 to 2 cm and variable throw options. The widely used
coaxial system (which consists of inserting a thin
inner needle through a larger outer needle placed at
the edge or within the lesion) has numerous
advantages over the single needle technique including
limiting the number of pleural punctures, a reduced
pneumothorax rate, and the opportunity to obtain
multiple specimens.
CT-guided coaxial cutting needle biopsy has been
used as an initial method for transthoracic biopsy of
focal lung and mediastinal lesions. Recently coaxial
models with small diameters have become available
allowing multiple core specimens with a single pleural
puncture (5). Yeow and colleagues reported that they
obtained 3 specimens on every biopsy procedure with
95% overall diagnostic accuracy and diagnostic
accuracy rates of 99% and 86% for malignant and
benign lesions, respectively (6). A larger and a more
recent study on this topic by Hiraki et al, which
included 901 patients and 1000 lesions, provided very
high diagnostic yields of CT guided coaxial technique
(7). The overall diagnostic accuracy was 95.2%. In
only 6 lesions (0.6%) the biopsy results were
nondiagnostic. Independent predictors of diagnostic
failure were identified as obtaining 2 or less
specimens, lesions in the lower lobe, malignant lesions
and small lesions with a diameter of 1 cm or less.
In the present study, the mean number of
specimens obtained in 1 attempt was 5.6, and the rate
of reaching a diagnosis was 87.4%. This ratio is in
accordance with the literature. These findings
demonstrate that using an appropriate method with
an adequate number of specimens provide high
diagnostic rate of the procedure.
In diagnosing pulmonary carcinoma, histology
offers no advantages over fine-needle aspiration.
Nevertheless, cutting needles have been shown to be
more accurate in diagnosing benign lesions and
lymphomas and when an on-site cytopathologist is
absent (8). In the present study, lymphoma was
diagnosed in 2 patients by cutting needle lung biopsy.
In 2 patients with hydatid cysts, since the lesion
looked like a solid mass lesion on thoracic CT and
there was no history or clinical signs of cystic disease,
a transthoracic lung biopsy was performed. In one
patient rheumatoid nodule was also demonstrated by
Tru-Cut needle biopsy. We think that, by obtaining

sufficient histologic specimens, the diagnosis can be
achieved in such situations. In 12.6% of our subjects,
biopsy specimens were not diagnostic. It was thought
that this might have resulted from sampling mistakes,
the inability to reach a small lesion, or taking the
specimens from the necrotic core or a peritumoral
fibrotic-inflammatory area.
Percutaneous biopsy of mediastinal or hilar lymph
nodes (to diagnose lung carcinoma) or enlarged
lymph nodes (to detect mediastinal invasion) is less
invasive than mediastinoscopy. CT-guided coaxial
cutting needle biopsy is safe; however, pneumothorax
and bleeding are the 2 most frequently encountered
complications. Pneumothorax remains the most
common complication of CT-guided lung biopsy. A
review of the existing literature reveals variable rates
of pneumothorax from 8% to 64% (9). This large
range for pneumothorax reflects both altered risk
from the location of the lesion and the increased
sensitivity of CT. A recent study by Yildirim et al.
revealed an overall complication rate of 39.1% (10).
Pneumothorax was the most common complication
developed in 26% of the cases, most of which were
mild (18.6%). No single factor was found to be an
independent predictor of the development of
pneumothorax. Bleeding was the second most
common complication in that study and lesion size
rather than lesion depth was identified as a predictor
of it. It has been reported that the rate of
pneumothoraces requiring treatment with chest tube
varies from 1.6% to 17% of the patients (3). When
pneumothorax is detected following biopsy,
management options include observation, aspiration,
or chest tube drainage. British Thoracic Society
guidelines on managing pneumothorax suggest initial
treatment by aspiration, with subsequent drainage if a
leak and significant pneumothorax persist; a small
gauge drain is usually adequate (11). In patients with
a large, symptomatic, and progressive pneumothorax,
usually a small bore chest tube is enough. Aspiration
of the air remaining after the procedure decreases the
need for placing a tube.
Yeow and associates reported that compared with
lesions with a diameter >4.1 cm, those with a diameter
of < 2 cm had an 11-fold increased risk of leading to
a pneumothorax. With respect to location, lesions
located near the pleura had higher rates of
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pneumothorax (12). Other research has shown that a
perihilar biopsy also is more likely to cause
pneumothoraces because of the distance of lung
crossed (13). In our study, when the patients were
divided according to diameter of the lesion, no
significant differences were observed among the 3
subgroups. We found that 59 of 270 patients (21.8%)
had a pneumothorax; in 2 of these patients, bleeding
was also detected. In 37 cases of pneumothorax,
following aspiration of the air in the pleural space via
a catheter, no increase in pneumothorax was detected,
and no further followed-up was required. However,
in 22 patients (38.6%), a pigtail chest tube was
inserted owing to an increase in the pneumothorax;
on follow-up, the pneumothorax regressed and no
surgical intervention was required. The rate of
pneumothorax in our study is in accordance with
previous reports. We think that aspiration of the air
in the pleural space decreases the need for a chest tube
insertion.

percutaneous biopsy. Hemorrhage occurs in
approximately 5% to 16.9% of patients undergoing
percutaneous biopsy. Hemoptysis occurs in 1.25% to
5% in most series and is slightly more frequent when
cutting needles are used (15,16). Intrapulmonary
hemorrhage may occur with or without hemoptysis.
Massive hemoptysis requiring bronchoscopic
tamponade, arterial embolization, or surgery has
become extremely rare with small caliber needles.
Lesion depth has been identified as the most
important risk factor for hemorrhage, with an
increased risk of bleeding in lesions deeper than 2 cm.
Hemorrhage was detected in 9 of our patients (3.3%).
In 2 patients, hemoptysis was noted, both were
nonmassive. In all of these patients, the bleeding
stopped spontaneously, so no intervention or blood
transfusion was needed. There was no relationship
between lesion location and bleeding. The lower rate
of hemorrhage might be due to the use of fine needles
and the biopsy technique.

Chronic obstructive pulmonary disorder and
hyperinflation; the size, depth, and location of the
lesion; a small angle of the needle with the thoracic
pleura; repositioning the needle multiple times; and,
numerous samples are among the risk factors
associated with increased risk of pneumothorax (14).
In the present study, location and size of the lesion,
the number of the biopsy specimens, and presence of
emphysema were not found to significantly affect the
complication rate.

Mortality from transthoracic lung biopsy is
generally an early event. The mortality rate of
percutaneous biopsy has been estimated globally as
being 0.002% of all patients, mainly due to systemic
air embolism, pericardial tamponade, and acute
massive hemoptysis (3). No death occurred in our
study population.

Hemorrhage, most often a self-limiting
complication, is the second most common and
potentially most dangerous complication of

In conclusion transthoracic biopsy using a coaxial
system is a well tolerated, minimally invasive
procedure, with a high rate of diagnosis, providing
reliable differentiation of malign and benign lesions,
with acceptable complication rates and high diagnosis
rate. It is a feasible procedure for focal lung lesions.
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